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Kaposi`s Sarcoma (KS) is the most common malignancy
in HIV-infected patients. It`s induced by an infection with
the Human Herpesvirus 8. AIDS-related Kaposi sarcoma
tends to have an aggressive clinical course because it may
involve all skin, membranes, lymph nodes, stomach, gut,
lung or liver.
A 32-year-old patient was diagnosed in 2009 with HIV
infection and disseminated KS. Purple macules and
nodules were disseminated on the trunk, limbs and lin-
gual mucosa. He was a late presenter with CD4-T cell
count 30 cells/µL and 108,000 copies/mL HIV-RNA.
With antiretroviral therapy (ART) the clinical, virological
and immunological evolution were very good: the CD4-T
cell count increased to 156 cells/µL and the viral load
was undetectable. Unfortunately, he became non adher-
ent, and after 2 years of absence he returned in very bad
condition with pericarditis, pleurisy, ascites and a low
CD4-T cell count (13 cells/µL). The changes showed by
the chest CT scan, the results of pleural biopsy, the clini-
cal findings raised the suspicion of disseminated KS and
miliary tuberculosis. Despite all the treatments (Mega-
ART, antituberculosis chemotherapy, opportunistic infec-
tions prophylaxis) the pericarditis and pleural fluid was
always recovered. Weekly thoracentesis were needed and
CD-4 T cell number had not increased as we expected
(the maximal value was 88 cells/µL), although the viremia
was undetectable.
There are 5 years since our patient was diagnosed
with HIV infection and disseminated KS. In front of a
patient with HIV-infection and symptomatic visceral or
pulmonary KS, regardless the viral load, cytotoxic che-
motherapy is recommended after the immunological
status is improved. Another option is thoracoscopic talc
pleurodesis which has been reported extremely effective
in the malignant pleural effusion.
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